- BridgeBio has developed a validated bioassay that directly measures glycosylated ⍺DG, which is central to LGMD2I disease, and enables monitoring of responses to disease-modifying therapies in LGMD2I ...
Bioassay Developers Are Using Statistics to Chase Down Stragglers and Showing Sensitivity to Mechanisms of Action to Keep Studies on Track Bioassays are scientific experiments involving the use of ...
Therapeutic antibodies are now the major class of successful protein drugs with many more in development to target a variety of major diseases. An important and desirable biological activity of most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback